MoonLake Immunotherapeutics (MLTX) — Financial Flexibility Index
MoonLake Immunotherapeutics (MLTX) has a Financial Flexibility Index of -0.45x as of March 2026. Free cash flow of $-66.29 Million (operating CF $-66.29 Million minus capex $0.00) represents 0% of total liabilities ($146.35 Million). Check MLTX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MoonLake Immunotherapeutics Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for MoonLake Immunotherapeutics across 6 annual periods. For the full cash flow conversion analysis, see cash flow conversion of MoonLake Immunotherapeutics.
Annual Financial Flexibility Index for MoonLake Immunotherapeutics (2020–2025)
Year-by-year free cash flow to debt coverage for MoonLake Immunotherapeutics. Explore debt repayment capacity of MoonLake Immunotherapeutics to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.63x | $-195.97 Million | $-196.01 Million | $119.95 Million | ▲ +65.5% |
| 2024 | -4.73x | $-116.07 Million | $-116.59 Million | $24.54 Million | ▼ -45.2% |
| 2023 | -3.26x | $-42.49 Million | $-42.78 Million | $13.05 Million | ▲ +52.9% |
| 2022 | -6.92x | $-55.88 Million | $-55.89 Million | $8.08 Million | ▼ -320.1% |
| 2021 | -1.65x | $-35.12 Million | $-35.18 Million | $21.33 Million | ▼ -2058.2% |
| 2020 | -0.08x | $-316.69K | $-316.69K | $4.15 Million | — |